
A clinical response to and some mechanisms of therapeutic action of extremely high frequency (EHF) therapy were studied in 132 patients with exacerbation of duodenal ulcer vs routine pharmacological treatment. EHF-therapy was used alone and in combination with famotidin (antisecretory drug) and norfloxacine (antibacterial drug). EHF monotherapy proved highly effective in duodenal ulcer exacerbation. It normalizes secretory and motor functions of the stomach, suppresses initially high activity of free radical lipid oxidation, corrects abnormal vegetative and psychoemotional status of the patients, moderately potentiates the antihelicobacter effect of antibacterial drugs. These effects are produced due to specific action of EHF therapy: mobilisation of sanogenesis mechanisms, correction of mechanisms of adaptive regulation and self regulation at different levels. Additional administration of antisecretory and antibacterial drugs improved immediate but deteriorates long-term response to EHF-therapy.
Clinical Trials as Topic, Duodenal Ulcer, Humans, Anti-Ulcer Agents, Famotidine, Electromagnetic Phenomena
Clinical Trials as Topic, Duodenal Ulcer, Humans, Anti-Ulcer Agents, Famotidine, Electromagnetic Phenomena
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
